Bluebell said to build Bayer stake in breakup push, Bloomberg reports

Activist investor Bluebell Capital Partners has built a stake in Bayer and is pushing for a breakup of the German pharmaceutical and agriculture company, Bloomberg’s Crystal Tse, Swetha Gopinath, and Aaron Kirchfeld report, citing people familiar with the matter. Bluebell, which has amassed an undisclosed holding in Bayer, is also seeking an overhaul of the company’s corporate governance, according to the people. It has been speaking to Bayer’s supervisory board behind the scenes over the past few months, the sources added. Reference Link